| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034679596 |
| P356 | DOI | 10.1186/1472-6823-12-33 |
| P932 | PMC publication ID | 3556156 |
| P698 | PubMed publication ID | 23237320 |
| P5875 | ResearchGate publication ID | 233913022 |
| P50 | author | Simon Heller | Q38550003 |
| Lalantha Leelarathna | Q42853790 | ||
| Jane Speight | Q53302735 | ||
| Mark L. Evans | Q53517846 | ||
| Pratik Choudhary | Q57420540 | ||
| P2093 | author name string | David Kerr | |
| Daniel Flanagan | |||
| Emma Walkinshaw | |||
| Sally M Marshall | |||
| Stuart Little | |||
| Thomas Chadwick | |||
| Tolulope Olateju | |||
| Shalleen Barendse | |||
| Cath Brennand | |||
| Reena M Thomas | |||
| James Am Shaw | |||
| Horng K Tan | |||
| Julia Stickland | |||
| P2860 | cites work | Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus | Q24240609 |
| Blood glucose awareness training delivered over the internet | Q24649941 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials | Q28185637 | ||
| EuroQol--a new facility for the measurement of health-related quality of life | Q29547873 | ||
| Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms | Q30463772 | ||
| Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes | Q33180598 | ||
| Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments | Q34153575 | ||
| Symptoms of hypoglycaemia in people with diabetes | Q34404995 | ||
| Diagnosis and classification of diabetes mellitus | Q34425060 | ||
| Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes | Q34718324 | ||
| Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes | Q34756826 | ||
| Hypoglycemia in diabetes. | Q35135643 | ||
| Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial | Q36575356 | ||
| The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness | Q36823526 | ||
| Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study | Q37054992 | ||
| Diabetes prevalence in England, 2001--estimates from an epidemiological model | Q40356098 | ||
| Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis | Q41070872 | ||
| Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes | Q41976344 | ||
| Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group | Q42612090 | ||
| Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group | Q42669531 | ||
| Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes | Q43001906 | ||
| Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia | Q44243542 | ||
| Unexplained Deaths of Type 1 Diabetic Patients | Q44307774 | ||
| Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart | Q44333388 | ||
| Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime | Q44418827 | ||
| Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection | Q44518159 | ||
| A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine | Q44953969 | ||
| Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin | Q45118534 | ||
| Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin | Q45218162 | ||
| Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. | Q45285681 | ||
| Continuous glucose monitoring and intensive treatment of type 1 diabetes | Q46380752 | ||
| Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy | Q46654314 | ||
| A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone. | Q50993128 | ||
| Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. | Q51556027 | ||
| A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group. | Q51556699 | ||
| Development and validation of the insulin treatment satisfaction questionnaire. | Q51663794 | ||
| Investigations of the functional anatomy of attention using the Stroop test. | Q52223282 | ||
| Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. | Q52307563 | ||
| The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. | Q53557993 | ||
| Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring | Q56093368 | ||
| Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes | Q57413008 | ||
| Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM | Q57420328 | ||
| Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes | Q57420344 | ||
| Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group | Q70133376 | ||
| Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM | Q70495234 | ||
| Development of scales to measure perceived control of diabetes mellitus and diabetes-related health beliefs | Q72841346 | ||
| Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia | Q72874429 | ||
| Reversibility of unawareness of hypoglycemia in patients with insulinomas | Q72890228 | ||
| Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes | Q73143654 | ||
| An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes | Q80117512 | ||
| Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes | Q81011993 | ||
| Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes | Q81294679 | ||
| P921 | main subject | hypoglycemia | Q202758 |
| P304 | page(s) | 33 | |
| P577 | publication date | 2012-12-13 | |
| P1433 | published in | BMC Endocrine Disorders | Q4835945 |
| P1476 | title | Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial) | |
| P478 | volume | 12 |
| Q30279237 | Characterizing problematic hypoglycaemia: iterative design and preliminary psychometric validation of the Hypoglycaemia Awareness Questionnaire (HypoA-Q). |
| Q90351040 | Differentiating hypoglycemia awareness status from hypoglycemia experience in tools for measuring impaired awareness of hypoglycemia |
| Q38651610 | Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices |
| Q37331320 | Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial |
Search more.